FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2055046903> ?p ?o ?g. }

• W2055046903 endingPage "357" @default.
• W2055046903 startingPage "327" @default.
• W2055046903 abstract "The current United States Environmental Protection Agency (EPA) classification of di(2-ethylhexyl)phthalate (DEHP) as a B2 probable human carcinogen is based on outdated information. New toxicology data and a considerable amount of new mechanistic evidence were used to reconsider the cancer classification of DEHP under EPA's proposed new cancer risk assessment guidelines. The total weight-of-evidence clearly indicates that DEHP is not genotoxic. In vivo administration of DEHP to rats and mice results in peroxisome proliferation in the liver, and there is strong evidence and scientific consensus that, in rodents, peroxisome proliferation is directly associated with the onset of liver cancer. Peroxisome proliferation is a transcription-mediated process that involves activation by the peroxisome proliferator of a nuclear receptor in rodent liver called the peroxisome proliferator-activated receptor (PPARalpha). The critical role of PPARalpha in peroxisomal proliferation and carcinogenicity in mice is clearly established by the lack of either response in mice genetically modified to remove the PPARalpha. Several mechanisms have been proposed to explain how, in rodents, peroxisome proliferation can lead to the formation of hepatocellular tumors. The general consensus of scientific opinion is that PPARalpha-induced mitogenesis and cell proliferation are probably the major mechanisms responsible for peroxisome proliferator-induced hepatocarcinogenesis in rodents. Oxidative stress appears to play a significant role in this increased cell proliferation. It triggers the release of TNFalpha by Kupffer cells, which in turn acts as a potent mitogen in hepatocytes. Rats and mice are uniquely responsive to the morphological, biochemical, and chronic carcinogenic effects of peroxisome proliferators, while guinea pigs, dogs, nonhuman primates, and humans are essentially nonresponsive or refractory; Syrian hamsters exhibit intermediate responsiveness. These differences are explained, in part, by marked interspecies variations in the expression of PPARalpha, with levels of expression in humans being only 1-10% of the levels found in rat and mouse liver. Recent studies of DEHP clearly indicate a nonlinear dose-response curve that strongly suggests the existence of a dose threshold below which tumors in rodents are not induced. Thus, the hepatocarcinogenic effects of DEHP in rodents result directly from the receptor-mediated, threshold-based mechanism of peroxisome proliferation, a well-understood process associated uniquely with rodents. Since humans are quite refractory to peroxisomal proliferation, even following exposure to potent proliferators such as hypolipidemic drugs, it is concluded that the hepatocarcinogenic response of rodents to DEHP is not relevant to human cancer risk at any anticipated exposure level. DEHP should be classified an unlikely human carcinogen with a margin of exposure (MOE) approach to risk assessment. The most appropriate and conservative point of reference for assessing MOEs should be 20 mg/kg/day, which is the mouse NOEL for peroxisome proliferation and increased liver weight. Exposure of the general human population to DEHP is approximately 30 microg/kg body wt/day, the major source being from residues in food. Higher exposures occur occupationally [up to about 700 microg/kg body wt/day (mainly by inhalation) based on current workplace standards] and through use of certain medical devices [e.g., up to 457 microg/kg body wt/day for hemodialysis patients (intravenous)], although these have little relevance because the routes of exposure bypass critical activation enzymes in the gastrointestinal tract." @default.
• W2055046903 created "2016-06-24" @default.
• W2055046903 creator A5003203034 @default.
• W2055046903 creator A5018569092 @default.
• W2055046903 creator A5026876414 @default.
• W2055046903 creator A5053155020 @default.
• W2055046903 creator A5055623670 @default.
• W2055046903 creator A5070031416 @default.
• W2055046903 creator A5072623198 @default.
• W2055046903 creator A5078180176 @default.
• W2055046903 date "1999-06-01" @default.
• W2055046903 modified "2023-09-30" @default.
• W2055046903 title "A Cancer Risk Assessment of Di(2-ethylhexyl)phthalate: Application of the New U.S. EPA Risk Assessment Guidelines" @default.
• W2055046903 cites W1486361410 @default.
• W2055046903 cites W1490755489 @default.
• W2055046903 cites W1503187067 @default.
• W2055046903 cites W1505590932 @default.
• W2055046903 cites W1535106643 @default.
• W2055046903 cites W1539647070 @default.
• W2055046903 cites W1562618110 @default.
• W2055046903 cites W1798702976 @default.
• W2055046903 cites W1891279885 @default.
• W2055046903 cites W19140683 @default.
• W2055046903 cites W1963874292 @default.
• W2055046903 cites W1966064883 @default.
• W2055046903 cites W1966304562 @default.
• W2055046903 cites W1968642969 @default.
• W2055046903 cites W1971977338 @default.
• W2055046903 cites W1975877903 @default.
• W2055046903 cites W1978129373 @default.
• W2055046903 cites W1980251642 @default.
• W2055046903 cites W1981142691 @default.
• W2055046903 cites W1982728225 @default.
• W2055046903 cites W1984551431 @default.
• W2055046903 cites W1985400591 @default.
• W2055046903 cites W1985696650 @default.
• W2055046903 cites W1987311481 @default.
• W2055046903 cites W1987620723 @default.
• W2055046903 cites W1987892320 @default.
• W2055046903 cites W1988565626 @default.
• W2055046903 cites W1989202489 @default.
• W2055046903 cites W1990363890 @default.
• W2055046903 cites W1992878034 @default.
• W2055046903 cites W1993965116 @default.
• W2055046903 cites W1994763926 @default.
• W2055046903 cites W1996520281 @default.
• W2055046903 cites W1998149331 @default.
• W2055046903 cites W1998329217 @default.
• W2055046903 cites W1999409684 @default.
• W2055046903 cites W2003555296 @default.
• W2055046903 cites W2003960793 @default.
• W2055046903 cites W2003982678 @default.
• W2055046903 cites W2005411425 @default.
• W2055046903 cites W2006016615 @default.
• W2055046903 cites W2006692886 @default.
• W2055046903 cites W2011147159 @default.
• W2055046903 cites W2011283553 @default.
• W2055046903 cites W2013127992 @default.
• W2055046903 cites W2015189231 @default.
• W2055046903 cites W2015697520 @default.
• W2055046903 cites W2017564027 @default.
• W2055046903 cites W2019212738 @default.
• W2055046903 cites W2019944097 @default.
• W2055046903 cites W2020780267 @default.
• W2055046903 cites W2020995626 @default.
• W2055046903 cites W2021657137 @default.
• W2055046903 cites W2021992061 @default.
• W2055046903 cites W2023697788 @default.
• W2055046903 cites W2029930839 @default.
• W2055046903 cites W2031633834 @default.
• W2055046903 cites W2033680066 @default.
• W2055046903 cites W2034109514 @default.
• W2055046903 cites W2037043378 @default.
• W2055046903 cites W2039423436 @default.
• W2055046903 cites W2040522735 @default.
• W2055046903 cites W2040918147 @default.
• W2055046903 cites W2041956872 @default.
• W2055046903 cites W2043975977 @default.
• W2055046903 cites W2045984034 @default.
• W2055046903 cites W2048384760 @default.
• W2055046903 cites W2049639877 @default.
• W2055046903 cites W2050806539 @default.
• W2055046903 cites W2050911758 @default.
• W2055046903 cites W2056034817 @default.
• W2055046903 cites W2058967307 @default.
• W2055046903 cites W2060784134 @default.
• W2055046903 cites W2061998185 @default.
• W2055046903 cites W2064656679 @default.
• W2055046903 cites W2065107673 @default.
• W2055046903 cites W2066166372 @default.
• W2055046903 cites W2067658197 @default.
• W2055046903 cites W2070123035 @default.
• W2055046903 cites W2072157913 @default.
• W2055046903 cites W2074934710 @default.
• W2055046903 cites W2076884184 @default.
• W2055046903 cites W2077536826 @default.
• W2055046903 cites W2080721799 @default.
• W2055046903 cites W2081422436 @default.

• next